Literature DB >> 3166342

Blood genetic markers in Sri Lankan populations--reappraisal of the legend of Prince Vijaya.

N Saha1.   

Abstract

Serum protein (haptoglobin types; transferrin and group-specific component subtypes); haemoglobin and red cell enzymes (acid phosphatase, esterase D, glyoxalase I, 6-phosphogluconate dehydrogenase, adenylate kinase, and phosphoglucomutase (locus 1) (subtypes) were studied in the Sinhalese, Tamils, and Muslims of Sri Lanka. The allelic frequencies of all the polymorphic systems were similar in these populations without any significant differences. A close look at the present results and earlier investigations on 13 polymorphic loci controlled by 37 alleles did not reveal any genetic characteristics in the present-day Sinhalese population that are distinct from those in the Tamils of Sri Lanka. As such, genetic evidence linking the legendary origin of the Sinhalese population to East India (Prince Vijaya) is lacking.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3166342     DOI: 10.1002/ajpa.1330760210

Source DB:  PubMed          Journal:  Am J Phys Anthropol        ISSN: 0002-9483            Impact factor:   2.868


  4 in total

1.  Root and canal morphology of permanent mandibular molars in a Sri Lankan population.

Authors:  Roshan Peiris; Masami Takahashi; Kayoko Sasaki; Eisaku Kanazawa
Journal:  Odontology       Date:  2007-07-25       Impact factor: 2.634

2.  Debrisoquine and mephenytoin oxidation in Sinhalese: a population study.

Authors:  K Weerasuriya; R L Jayakody; C A Smith; C R Wolf; G T Tucker; M S Lennard
Journal:  Br J Clin Pharmacol       Date:  1994-11       Impact factor: 4.335

3.  Genetic variants in the cytochrome P450 2D6 gene in the Sri Lankan population.

Authors:  T D Praveen Tharanga; C M V Jinadasa; M F Risama; Priyadarshani Galappatthy; R L Jayakody; Vajira H W Dissanayake
Journal:  Indian J Hum Genet       Date:  2013-10

4.  Genetic diversity of variants involved in drug response and metabolism in Sri Lankan populations: implications for clinical implementation of pharmacogenomics.

Authors:  Sze Ling Chan; Nilakshi Samaranayake; Colin J D Ross; Meng Tiak Toh; Bruce Carleton; Michael R Hayden; Yik Ying Teo; Vajira H W Dissanayake; Liam R Brunham
Journal:  Pharmacogenet Genomics       Date:  2016-01       Impact factor: 2.089

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.